US House Advances Bill Targeting Chinese Biotech Firms

The Biosecure Act seeks to reduce dependence on Chinese biotech companies over national security concerns, moving through Congress with bipartisan support.

• The House Committee on Oversight and Accountability approved the Biosecure Act 40-1.
• The bill aims to restrict US business with BGI, WuXi AppTec, WuXi Biologics, and other Chinese biotech firms.
• US companies have until 2032 to end contracts with the targeted Chinese firms.
• The legislation also bans federal agencies from using equipment or services from these companies.
• Chinese biotech firms argue the bill is based on false allegations and would harm competition.

4 Articles

Quartz Denver Gazette South China Morning Post Stat News